Skip to main content
News

Crystallization Prompts Recalls of Tissue Softeners

The US Food and Drug Administration (FDA) announced two recalls of medications used to soften tissue.

What prompted the Class III recall? The manufacturer, Sonar Products Inc. of New Jersey, received complaints that the cream had crystallized.

__________________________________________________________________________________________________________________________________________________________________________

RELATED CONTENT
Antibiotic Recalled Due to Iron Oxide Particulates
Asthma Med Recalled
__________________________________________________________________________________________________________________________________________________________________________

More than 20,000 tubes of Remeven cream (50% urea in a cream base) are being recalled by Stratus Pharmaceuticals Inc. of Florida.

Presentation

Lot

Expiration

NDC

142 g

8020

02/17

58980-680-50

142 g

8096

07/18

58980-680-50

142 g

8125

08/18

58980-680-50

142 g

8169

10/18

58980-680-50

255 g

8020

02/17

58980-680-90

255 g

8125

08/18

58980-680-90

255 g

8170

10/18

58980-680-90

More than 6,300 tubes of urea (50% urea in a cream base) are being recalled by Exact-Rx Inc. of New York.

Presentation

Lot

Expiration

NDC

142 g

8160

September 2018

42808-0200-05

255 g

8160

September 2018

42808-0200-09

The impacted products were distributed nationwide and in Puerto Rico.

 

--Stephanie Vaccaro

 

Reference:

US Food and Drug Administration. FDA Enforcement Report – Week of August 31, 2016. www.fda.gov. Accessed August 31, 2016.